MY
Mymetics Corporation
MYMX · OTC
$0.00 +0.00% (+$0.00)
Market Cap 39.0 €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 69.99%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 47,966.70%
Net margin 160,167.00%
Op. margin 58,166.70%
Quality
0 /100
Poor ROIC 24.57%
ROA 65.63%
Asset turnover 0.00x
Debt
50 /100
Moderate Current ratio 0.01x
Int. coverage -0.72x
Net debt/EBITDA -36.02x
Stability
1 /100
Unstable Beta 2.36x
Rev. volatility 47.56%
EPS volatility 98,194.22%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MYMX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald Kempers
Employees
2
Headquarters
Epalinges